Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06500169 · ClinicalTrials.gov registry record · NA

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

A NA study of Stage III Prostate Cancer AJCC v8 and Stage II Prostate Cancer AJCC v8, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06500169 is a NA study of Stage III Prostate Cancer AJCC v8 and Stage II Prostate Cancer AJCC v8 that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 20 participants, below the 249-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06500169, a NA study of Stage III Prostate Cancer AJCC v8 and Stage II Prostate Cancer AJCC v8, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Exercise Intervention
  • OTHER Medical Device Usage and Evaluation
  • OTHER Interview
  • PROCEDURE Discussion

Study Locations (2)

California

  • Los Angeles General Medical Center - Los Angeles
  • USC / Norris Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-09-01
Est. Completion 2027-09-01
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT06500169

The ClinicalTrials.gov registry entry for NCT06500169 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 249-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (92% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Stage III Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT06500169 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06500169 about?

NCT06500169 is a clinical study titled "Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors". This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrai...

What is the current status of trial NCT06500169?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-09-01. Estimated completion is 2027-09-01.

What conditions does trial NCT06500169 study?

This clinical trial studies the following conditions: Stage III Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Localized Prostate Carcinoma, Locally Advanced Prostate Carcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8.

What interventions are being tested in trial NCT06500169?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Exercise Intervention (OTHER), Medical Device Usage and Evaluation (OTHER), Interview (OTHER), Discussion (PROCEDURE).

Who is sponsoring clinical trial NCT06500169?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06500169 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stage III Prostate Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.